Cinryze 500 unit vial-diluents

Ended Awarded Last action

Contract number
SPE2DR26FCSQ7
Awardee
Awarding agency
Obligated
$45,036

Award facts

Contract value 100% obligated
$45,036.20 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on May 4, 2026, for CINRYZE 500 unit vial-diluents, with a ceiling value of $45,036.20 under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V).

DMS Pharmaceutical Group Inc. is a woman-owned small business. The order is issued under the Defense Logistics Agency's single-award indefinite delivery contract SPE2DX, a $499.999 billion pharmaceutical supply vehicle with an ultimate completion date of December 31, 2036. Place of performance is Park Ridge, IL. The delivery order is firm fixed-price with an ultimate completion date of May 26, 2026.

Quick answers

Who was awarded contract SPE2DR26FCSQ7?

SPE2DR26FCSQ7 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on May 4, 2026.

How much is contract SPE2DR26FCSQ7 worth?

The government has obligated $45,036 on SPE2DR26FCSQ7.

Is contract SPE2DR26FCSQ7 an order under another contract?

Yes. SPE2DR26FCSQ7 is a delivery order under SPE2DR25D9168, an indefinite delivery contract.

Was contract SPE2DR26FCSQ7 competed?

The extent of competition for SPE2DR26FCSQ7 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award